SCHEMBL7714740

SCHEMBL7714740

NOC(=O)/C=C/c1ccc2ccn(Cc3ccccc3)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.67
HDAC1 Q13547 4/20 0.57
HDAC8 Q9BY41 4/20 0.57
HDAC3 O15379 3/20 0.57
HDAC2 Q92769 3/20 0.57
HDAC10 Q969S8 3/20 0.57
HDAC6 Q9UBN7 3/20 0.57
HDAC4 P56524 2/20 0.57
HDAC7 Q8WUI4 2/20 0.57
HDAC11 Q96DB2 2/20 0.57
HDAC9 Q9UKV0 2/20 0.57
HDAC5 Q9UQL6 2/20 0.57
APP P05067 7/20 0.56
SNCA P37840 4/20 0.56
NPC1 O15118 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HTR6 P50406 1/20 0.44
BRD4 O60885 2/20 0.43
AKR1B10 O60218 2/20 0.42
TTR P02766 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712587 0.91 HDAC1 (0.70) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL8388266 0.87 BACE1 (0.74) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL7712177 0.81 HDAC8 (0.56) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL3206211 0.81 BACE1 (1.00) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL3206225 0.81 BACE1 (1.00) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL7712584 0.80 HDAC8 (0.55) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL7712179 0.79 HDAC6 (0.62) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL3222973 0.77 APP (0.64) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL3198178 0.77 BACE1 (0.73) BACE1HDAC1HDAC8HDAC3HDAC2
SCHEMBL3198163 0.77 BACE1 (0.73) BACE1HDAC1HDAC8HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598364-B2 Indolyl or indolinyl hydroxamate compounds TAIPEI MEDICAL UNIVERSITY (TW) 2017-03-21 US disclosed
US-20140364477-A1 INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS TAIPEI MEDICAL UNIVERSITY (TW) 2014-12-11 US disclosed
US-8846748-B2 Indolyl or indolinyl hydroxamate compounds TAIPEI MEDICAL UNIVERSITY (TW) 2014-09-30 US disclosed
US-20110245315-A1 INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS TAIPEI MEDICAL UNIVERSITY (TW) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245315-A1 INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS IDH3A, IDH2, IDH3B BACE1 3896/4885HDAC1 8/4885HDAC8 128/4885
US-20140364477-A1 INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS IDH3A, IDH2, IDH3B BACE1 3896/4885HDAC1 8/4885HDAC8 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.